001     137567
005     20240229105110.0
024 7 _ |a 10.1084/jem.20180008
|2 doi
024 7 _ |a pmid:30194265
|2 pmid
024 7 _ |a 0022-1007
|2 ISSN
024 7 _ |a 1540-9538
|2 ISSN
024 7 _ |a altmetric:47965234
|2 altmetric
037 _ _ |a DKFZ-2018-01447
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Singhal, Mahak
|0 P:(DE-He78)1956b17ee4a34a5fdd72287aca7cdc0a
|b 0
|e First author
245 _ _ |a Endothelial cell fitness dictates the source of regenerating liver vasculature.
260 _ _ |a New York, NY
|c 2018
|b Rockefeller Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1660198382_9214
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a DKFZ-ZMBH Allianz
520 _ _ |a Neoangiogenesis plays a key role in diverse pathophysiological conditions, including liver regeneration. Yet, the source of new endothelial cells (ECs) remains elusive. By analyzing the regeneration of the liver vasculature in irradiation-based myeloablative and nonmyeloablative bone marrow transplantation mouse models, we discovered that neoangiogenesis in livers with intact endothelium was solely mediated by proliferation of resident ECs. However, following irradiation-induced EC damage, bone marrow-derived mononuclear cells were recruited and incorporated into the vasculature. Further experiments with direct bone marrow infusion or granulocyte colony-stimulating factor (G-CSF)-mediated progenitor cell mobilization, which resembles clinically relevant stem cell therapy, demonstrated that bone marrow-derived cells did not contribute to the regeneration of liver vasculature after two-thirds partial hepatectomy (PHx). Taken together, the data reconcile many of the discrepancies in the literature and highlight that the cellular source of regenerating endothelium depends on the fitness of the residual vasculature.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Liu, Xiaoting
|b 1
700 1 _ |a Inverso, Donato
|0 P:(DE-He78)a2d0ba20ff9bcfeccbdab04513fbf8f0
|b 2
700 1 _ |a Jiang, Kai
|b 3
700 1 _ |a Dai, Jianing
|b 4
700 1 _ |a He, Hao
|b 5
700 1 _ |a Bartels, Susanne
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Li, Weiping
|b 7
700 1 _ |a Abdul Pari, Ashik Ahmed
|0 P:(DE-He78)81cd72bf4d0bacc59dc1d2b3b5c27be7
|b 8
700 1 _ |a Gengenbacher, Nicolas
|0 P:(DE-He78)d2851af71b2aced0c34d8c71329c3bc5
|b 9
700 1 _ |a Besemfelder, Eva
|0 P:(DE-He78)9be9200416a88a73cc9c25339b19b58f
|b 10
700 1 _ |a Hui, Lijian
|b 11
700 1 _ |a Augustin, Hellmut
|0 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b
|b 12
|e Last author
700 1 _ |a Hu, Junhao
|0 0000-0003-0699-1119
|b 13
773 _ _ |a 10.1084/jem.20180008
|g p. jem.20180008 -
|0 PERI:(DE-600)1477240-1
|n 10
|p 2497-2508
|t Journal of experimental medicine
|v 215
|y 2018
|x 1540-9538
909 C O |p VDB
|o oai:inrepo02.dkfz.de:137567
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)1956b17ee4a34a5fdd72287aca7cdc0a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)a2d0ba20ff9bcfeccbdab04513fbf8f0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)81cd72bf4d0bacc59dc1d2b3b5c27be7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)d2851af71b2aced0c34d8c71329c3bc5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)9be9200416a88a73cc9c25339b19b58f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Signalling pathways, cell and tumor biology
|x 0
914 1 _ |y 2018
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J EXP MED : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b J EXP MED : 2015
920 1 _ |0 I:(DE-He78)A190-20160331
|k A190
|l A190 Vaskuläre Onkologie und Metastasierung
|x 0
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A190-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21